Stock 6935 PRINCE PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Prince Pharmaceutical Co., Ltd.

Equities

6935

TW0006935000

Food Processing

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
28 TWD +2.38% Intraday chart for Prince Pharmaceutical Co., Ltd. +5.26% -20.00%
03-25 Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2023
Capitalization 1 1,267
Enterprise Value (EV) 1 1,635
P/E ratio 83.3 x
Yield -
Capitalization / Revenue 1.68 x
EV / Revenue 2.17 x
EV / EBITDA 21.5 x
EV / FCF -465,021,053 x
FCF Yield -0%
Price to Book 1.64 x
Nbr of stocks (in thousands) 36,193
Reference price 2 35.00
Announcement Date 25/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 249.6 295.8 441.1 712.5 753.3
EBITDA 1 -0.003 -26.52 40.05 112.9 75.94
EBIT 1 -9.305 -50.28 -1.112 67.76 25.78
Operating Margin -3.73% -17% -0.25% 9.51% 3.42%
Earnings before Tax (EBT) 1 0.014 -41.44 -10.31 64.2 19.17
Net income 1 0.009 -33.8 -8.302 51.55 15.31
Net margin 0% -11.43% -1.88% 7.24% 2.03%
EPS 2 0.000280 -1.033 -0.2501 1.550 0.4200
Free Cash Flow - -184.8 4.07 46.01 -3.515
FCF margin - -62.47% 0.92% 6.46% -0.47%
FCF Conversion (EBITDA) - - 10.16% 40.75% -
FCF Conversion (Net income) - - - 89.25% -
Dividend per Share - - - 0.1500 -
Announcement Date 10/11/22 10/11/22 10/11/22 21/04/23 25/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 301 468 493 451 368
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) -100,210 x -17.65 x 12.32 x 3.996 x 4.843 x
Free Cash Flow - -185 4.07 46 -3.52
ROE (net income / shareholders' equity) - -5.49% -1.37% 8.18% 2.14%
ROA (Net income/ Total Assets) - -2.65% -0.06% 3.26% 1.19%
Assets 1 - 1,275 14,986 1,579 1,290
Book Value Per Share 2 19.30 18.40 18.20 19.80 21.40
Cash Flow per Share 2 5.460 1.720 2.180 2.170 3.390
Capex 1 183 187 41 19.5 62.1
Capex / Sales 73.19% 63.06% 9.29% 2.74% 8.24%
Announcement Date 10/11/22 10/11/22 10/11/22 21/04/23 25/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
PRINCE PHARMACEUTICAL CO., LTD. Stock Prince Pharmaceutical Co., Ltd.
-20.00% 31.2M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.21% 8.12B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.08% 7.45B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
-17.32% 4.88B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-8.76% 3.62B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-20.43% 3.17B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-11.51% 1.21B
HERBALIFE LTD. Stock Herbalife Ltd.
-31.91% 1.04B
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-8.57% 879M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-15.60% 862M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 6935 Stock
  4. Financials Prince Pharmaceutical Co., Ltd.